 Sarkis Derderian
Concepts (244)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernias, Diaphragmatic, Congenital | 8 | 2024 | 201 | 3.120 |
Why?
| | Obesity, Morbid | 5 | 2020 | 257 | 2.160 |
Why?
| | Bariatric Surgery | 4 | 2020 | 213 | 2.070 |
Why?
| | Fetal Diseases | 5 | 2025 | 171 | 1.870 |
Why?
| | Fetal Therapies | 7 | 2015 | 39 | 1.650 |
Why?
| | Fetal Blood | 3 | 2025 | 327 | 1.610 |
Why?
| | Teratoma | 2 | 2025 | 114 | 1.390 |
Why?
| | Cystic Adenomatoid Malformation of Lung, Congenital | 2 | 2023 | 5 | 1.320 |
Why?
| | Body Contouring | 2 | 2020 | 8 | 1.310 |
Why?
| | Myasthenia Gravis | 2 | 2020 | 23 | 1.300 |
Why?
| | MicroRNAs | 2 | 2024 | 703 | 1.100 |
Why?
| | Airway Obstruction | 2 | 2025 | 162 | 1.000 |
Why?
| | Respiratory System Abnormalities | 2 | 2023 | 16 | 0.970 |
Why?
| | Pregnancy | 20 | 2025 | 6715 | 0.950 |
Why?
| | Ultrasonography, Prenatal | 8 | 2025 | 284 | 0.950 |
Why?
| | Blood Banks | 1 | 2025 | 41 | 0.950 |
Why?
| | Mediastinal Neoplasms | 1 | 2025 | 45 | 0.940 |
Why?
| | Hirudins | 1 | 2024 | 53 | 0.900 |
Why?
| | Antithrombins | 1 | 2024 | 59 | 0.890 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2024 | 290 | 0.880 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2023 | 8 | 0.860 |
Why?
| | Postoperative Hemorrhage | 1 | 2024 | 88 | 0.860 |
Why?
| | Hernia, Umbilical | 1 | 2023 | 16 | 0.850 |
Why?
| | Transplantation Conditioning | 2 | 2014 | 170 | 0.820 |
Why?
| | Heparin | 1 | 2024 | 259 | 0.810 |
Why?
| | Retrospective Studies | 27 | 2024 | 15514 | 0.800 |
Why?
| | Caloric Restriction | 1 | 2024 | 119 | 0.790 |
Why?
| | Specialties, Surgical | 2 | 2022 | 74 | 0.760 |
Why?
| | Infant, Newborn | 16 | 2025 | 6043 | 0.730 |
Why?
| | Wounds, Nonpenetrating | 2 | 2022 | 274 | 0.730 |
Why?
| | Catheterization, Central Venous | 2 | 2023 | 111 | 0.730 |
Why?
| | Empyema | 1 | 2021 | 5 | 0.710 |
Why?
| | Chest Tubes | 2 | 2023 | 29 | 0.700 |
Why?
| | Hematopoietic Stem Cell Transplantation | 3 | 2018 | 613 | 0.700 |
Why?
| | Weight Loss | 3 | 2020 | 765 | 0.700 |
Why?
| | Peptide Fragments | 1 | 2024 | 707 | 0.690 |
Why?
| | Thymectomy | 1 | 2019 | 15 | 0.660 |
Why?
| | Empyema, Pleural | 1 | 2019 | 12 | 0.650 |
Why?
| | Anticoagulants | 1 | 2024 | 662 | 0.650 |
Why?
| | Colonic Pouches | 1 | 2019 | 15 | 0.650 |
Why?
| | Head and Neck Neoplasms | 1 | 2025 | 617 | 0.640 |
Why?
| | Thoracoscopy | 1 | 2019 | 56 | 0.630 |
Why?
| | Spinal Injuries | 1 | 2019 | 51 | 0.620 |
Why?
| | Trauma Centers | 1 | 2022 | 419 | 0.620 |
Why?
| | Colectomy | 1 | 2019 | 99 | 0.620 |
Why?
| | Laparoscopy | 2 | 2020 | 464 | 0.610 |
Why?
| | Colitis, Ulcerative | 1 | 2019 | 130 | 0.580 |
Why?
| | Humans | 51 | 2025 | 136899 | 0.570 |
Why?
| | Sacrococcygeal Region | 1 | 2017 | 7 | 0.570 |
Why?
| | Forecasting | 1 | 2019 | 386 | 0.560 |
Why?
| | Amniotic Band Syndrome | 2 | 2014 | 4 | 0.560 |
Why?
| | Fetoscopy | 2 | 2014 | 26 | 0.550 |
Why?
| | Hematopoietic Stem Cells | 3 | 2016 | 398 | 0.540 |
Why?
| | Fibrinolytic Agents | 1 | 2019 | 271 | 0.540 |
Why?
| | Bacteremia | 1 | 2018 | 209 | 0.510 |
Why?
| | Female | 30 | 2025 | 72703 | 0.500 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 302 | 0.480 |
Why?
| | Magnetic Resonance Imaging | 4 | 2024 | 3710 | 0.470 |
Why?
| | Thrombosis | 1 | 2018 | 368 | 0.460 |
Why?
| | Hydrops Fetalis | 1 | 2014 | 13 | 0.460 |
Why?
| | Surgeons | 1 | 2019 | 296 | 0.460 |
Why?
| | Betamethasone | 1 | 2014 | 20 | 0.460 |
Why?
| | Fetal Stem Cells | 1 | 2014 | 8 | 0.450 |
Why?
| | Hydrothorax | 1 | 2014 | 3 | 0.440 |
Why?
| | Placenta | 2 | 2024 | 749 | 0.420 |
Why?
| | Neoplasm Staging | 1 | 2017 | 1376 | 0.420 |
Why?
| | Adolescent | 13 | 2024 | 21402 | 0.410 |
Why?
| | Child | 15 | 2024 | 21896 | 0.410 |
Why?
| | Biomarkers | 1 | 2024 | 4148 | 0.410 |
Why?
| | Pediatric Obesity | 1 | 2020 | 588 | 0.400 |
Why?
| | Critical Illness | 1 | 2018 | 805 | 0.390 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2017 | 1057 | 0.350 |
Why?
| | Central Venous Catheters | 2 | 2023 | 51 | 0.350 |
Why?
| | Pediatrics | 1 | 2019 | 1119 | 0.350 |
Why?
| | Pulmonary Artery | 1 | 2015 | 1084 | 0.320 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2670 | 0.320 |
Why?
| | Prenatal Diagnosis | 4 | 2024 | 201 | 0.310 |
Why?
| | Prospective Studies | 4 | 2024 | 7543 | 0.310 |
Why?
| | Lung | 5 | 2024 | 4046 | 0.290 |
Why?
| | Antibodies, Monoclonal | 1 | 2014 | 1417 | 0.280 |
Why?
| | Pregnancy Outcome | 3 | 2014 | 410 | 0.270 |
Why?
| | Obesity | 1 | 2020 | 2966 | 0.270 |
Why?
| | Fetus | 3 | 2023 | 803 | 0.270 |
Why?
| | Pregnancy Trimester, Third | 2 | 2024 | 113 | 0.270 |
Why?
| | Lung Volume Measurements | 2 | 2023 | 46 | 0.260 |
Why?
| | Proto-Oncogene Proteins c-kit | 3 | 2018 | 67 | 0.260 |
Why?
| | Cholecystectomy | 2 | 2024 | 60 | 0.250 |
Why?
| | Morbidity | 2 | 2023 | 321 | 0.250 |
Why?
| | Adult | 11 | 2025 | 37595 | 0.250 |
Why?
| | Male | 14 | 2024 | 67308 | 0.240 |
Why?
| | Gestational Age | 4 | 2021 | 901 | 0.230 |
Why?
| | Biliary Dyskinesia | 1 | 2024 | 2 | 0.230 |
Why?
| | Micrognathism | 1 | 2024 | 18 | 0.220 |
Why?
| | California | 2 | 2017 | 423 | 0.220 |
Why?
| | Liver | 4 | 2023 | 1937 | 0.220 |
Why?
| | Amniotic Fluid | 1 | 2024 | 95 | 0.220 |
Why?
| | Ostomy | 1 | 2023 | 3 | 0.220 |
Why?
| | Length of Stay | 2 | 2019 | 1203 | 0.220 |
Why?
| | Thoracic Surgery, Video-Assisted | 2 | 2023 | 43 | 0.210 |
Why?
| | Follow-Up Studies | 3 | 2019 | 5126 | 0.210 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 38 | 0.210 |
Why?
| | Thoracotomy | 2 | 2023 | 75 | 0.210 |
Why?
| | Catheter-Related Infections | 1 | 2023 | 80 | 0.200 |
Why?
| | Pneumothorax | 1 | 2023 | 38 | 0.200 |
Why?
| | Steroids | 1 | 2023 | 166 | 0.200 |
Why?
| | Gastrectomy | 2 | 2020 | 120 | 0.200 |
Why?
| | Survival Rate | 3 | 2017 | 1972 | 0.200 |
Why?
| | Anorectal Malformations | 1 | 2024 | 112 | 0.190 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2022 | 21 | 0.190 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 113 | 0.190 |
Why?
| | Meningomyelocele | 1 | 2022 | 59 | 0.190 |
Why?
| | Funnel Chest | 1 | 2021 | 27 | 0.180 |
Why?
| | Infant | 6 | 2023 | 9408 | 0.180 |
Why?
| | Hydrocephalus | 1 | 2022 | 105 | 0.180 |
Why?
| | Analgesia, Epidural | 1 | 2021 | 33 | 0.180 |
Why?
| | Feasibility Studies | 1 | 2025 | 943 | 0.180 |
Why?
| | Recombinant Proteins | 1 | 2024 | 1357 | 0.180 |
Why?
| | Drainage | 2 | 2019 | 164 | 0.180 |
Why?
| | Laryngeal Diseases | 1 | 2021 | 31 | 0.170 |
Why?
| | Nerve Block | 1 | 2021 | 76 | 0.170 |
Why?
| | Wound Closure Techniques | 1 | 2020 | 10 | 0.170 |
Why?
| | Appendix | 1 | 2020 | 30 | 0.170 |
Why?
| | Young Adult | 6 | 2023 | 13157 | 0.160 |
Why?
| | Proctocolectomy, Restorative | 1 | 2019 | 20 | 0.160 |
Why?
| | Abdominoplasty | 1 | 2019 | 7 | 0.160 |
Why?
| | Injury Severity Score | 1 | 2022 | 522 | 0.160 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 20 | 0.160 |
Why?
| | Pilot Projects | 1 | 2024 | 1684 | 0.160 |
Why?
| | Tracheostomy | 1 | 2021 | 132 | 0.160 |
Why?
| | Odds Ratio | 1 | 2022 | 1063 | 0.150 |
Why?
| | Blood Loss, Surgical | 1 | 2019 | 101 | 0.150 |
Why?
| | Cell Lineage | 2 | 2018 | 346 | 0.150 |
Why?
| | Mice | 5 | 2024 | 17775 | 0.150 |
Why?
| | Appendicitis | 1 | 2020 | 130 | 0.150 |
Why?
| | Tranexamic Acid | 1 | 2018 | 39 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2024 | 557 | 0.150 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 195 | 0.140 |
Why?
| | Job Satisfaction | 1 | 2019 | 215 | 0.130 |
Why?
| | Case-Control Studies | 1 | 2024 | 3528 | 0.130 |
Why?
| | Maternal-Fetal Exchange | 2 | 2014 | 165 | 0.130 |
Why?
| | Treatment Outcome | 5 | 2024 | 10768 | 0.130 |
Why?
| | RNA, Messenger | 1 | 2024 | 2837 | 0.120 |
Why?
| | Incidence | 3 | 2017 | 2783 | 0.120 |
Why?
| | Seizures | 1 | 2018 | 427 | 0.120 |
Why?
| | Ultrasonography, Doppler | 1 | 2015 | 123 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2024 | 4281 | 0.120 |
Why?
| | Graft Survival | 1 | 2018 | 539 | 0.120 |
Why?
| | Cholelithiasis | 1 | 2014 | 37 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2022 | 830 | 0.110 |
Why?
| | Histocompatibility, Maternal-Fetal | 1 | 2014 | 2 | 0.110 |
Why?
| | Animals | 6 | 2024 | 36915 | 0.110 |
Why?
| | Biliary Tract Diseases | 1 | 2014 | 39 | 0.110 |
Why?
| | Injections | 1 | 2014 | 182 | 0.110 |
Why?
| | Injections, Intramuscular | 1 | 2014 | 128 | 0.110 |
Why?
| | Vascular Remodeling | 1 | 2015 | 190 | 0.110 |
Why?
| | Jaundice, Neonatal | 1 | 2013 | 9 | 0.110 |
Why?
| | Stem Cell Niche | 1 | 2014 | 54 | 0.110 |
Why?
| | Child, Preschool | 2 | 2019 | 11013 | 0.110 |
Why?
| | Carbolines | 1 | 2013 | 32 | 0.110 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2013 | 37 | 0.110 |
Why?
| | Mice, Inbred C57BL | 2 | 2014 | 5766 | 0.110 |
Why?
| | Bone Marrow | 1 | 2014 | 286 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 296 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2013 | 203 | 0.100 |
Why?
| | Echocardiography | 1 | 2015 | 659 | 0.100 |
Why?
| | Animals, Newborn | 1 | 2014 | 844 | 0.090 |
Why?
| | Biliary Atresia | 1 | 2013 | 162 | 0.090 |
Why?
| | Internship and Residency | 1 | 2022 | 1131 | 0.090 |
Why?
| | Prognosis | 2 | 2022 | 4011 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2016 | 844 | 0.090 |
Why?
| | Immunity, Innate | 1 | 2016 | 832 | 0.080 |
Why?
| | Risk Factors | 3 | 2022 | 10313 | 0.080 |
Why?
| | Graft Rejection | 1 | 2014 | 623 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 5730 | 0.080 |
Why?
| | Autoimmune Diseases | 1 | 2014 | 459 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2066 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2014 | 596 | 0.080 |
Why?
| | Evidence-Based Medicine | 2 | 2024 | 744 | 0.080 |
Why?
| | Pregnancy Complications | 1 | 2014 | 521 | 0.080 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1996 | 0.070 |
Why?
| | Hypertension, Pulmonary | 2 | 2015 | 1901 | 0.070 |
Why?
| | Chimerism | 2 | 2018 | 31 | 0.060 |
Why?
| | Anatomic Landmarks | 1 | 2024 | 29 | 0.060 |
Why?
| | Jaw | 1 | 2024 | 26 | 0.060 |
Why?
| | Anus, Imperforate | 1 | 2024 | 24 | 0.060 |
Why?
| | Diaphragm | 1 | 2023 | 42 | 0.050 |
Why?
| | Anal Canal | 1 | 2024 | 97 | 0.050 |
Why?
| | Digestive System Surgical Procedures | 1 | 2024 | 106 | 0.050 |
Why?
| | Glycerol | 1 | 2023 | 94 | 0.050 |
Why?
| | United States | 1 | 2020 | 14595 | 0.050 |
Why?
| | Rectum | 1 | 2024 | 185 | 0.050 |
Why?
| | Gastrostomy | 1 | 2023 | 113 | 0.050 |
Why?
| | Surgical Flaps | 1 | 2023 | 148 | 0.050 |
Why?
| | Glutathione | 1 | 2023 | 358 | 0.040 |
Why?
| | Obstetric Labor Complications | 1 | 2021 | 34 | 0.040 |
Why?
| | Evidence-Based Practice | 1 | 2023 | 222 | 0.040 |
Why?
| | Ultrasonography, Interventional | 1 | 2021 | 142 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 616 | 0.040 |
Why?
| | Surgical Stapling | 1 | 2020 | 14 | 0.040 |
Why?
| | Prenatal Care | 1 | 2022 | 288 | 0.040 |
Why?
| | Stomach | 1 | 2020 | 110 | 0.040 |
Why?
| | Recurrence | 1 | 2023 | 1058 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 122 | 0.040 |
Why?
| | Cesarean Section | 1 | 2021 | 187 | 0.040 |
Why?
| | Intestines | 1 | 2022 | 356 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2021 | 271 | 0.040 |
Why?
| | Mice, SCID | 1 | 2018 | 367 | 0.030 |
Why?
| | Curriculum | 1 | 2023 | 978 | 0.030 |
Why?
| | Polymers | 1 | 2020 | 495 | 0.030 |
Why?
| | Models, Animal | 1 | 2018 | 387 | 0.030 |
Why?
| | Cellular Microenvironment | 1 | 2016 | 84 | 0.030 |
Why?
| | Antibodies | 1 | 2018 | 414 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 312 | 0.030 |
Why?
| | San Francisco | 1 | 2015 | 52 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2016 | 394 | 0.030 |
Why?
| | Biliary Fistula | 1 | 2014 | 3 | 0.030 |
Why?
| | Rupture, Spontaneous | 1 | 2014 | 18 | 0.030 |
Why?
| | Perinatal Death | 1 | 2014 | 25 | 0.030 |
Why?
| | Fetal Death | 1 | 2014 | 55 | 0.030 |
Why?
| | Cellular Senescence | 1 | 2016 | 188 | 0.030 |
Why?
| | Watchful Waiting | 1 | 2015 | 80 | 0.030 |
Why?
| | Biliary Tract Surgical Procedures | 1 | 2014 | 25 | 0.030 |
Why?
| | Tadalafil | 1 | 2013 | 7 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 451 | 0.030 |
Why?
| | Second Messenger Systems | 1 | 2013 | 35 | 0.030 |
Why?
| | Aneuploidy | 1 | 2014 | 93 | 0.030 |
Why?
| | Enzyme Induction | 1 | 2013 | 90 | 0.030 |
Why?
| | Cyclic GMP | 1 | 2013 | 94 | 0.030 |
Why?
| | Georgia | 1 | 2013 | 84 | 0.030 |
Why?
| | Hernia, Diaphragmatic | 1 | 2013 | 65 | 0.030 |
Why?
| | Portal Vein | 1 | 2014 | 117 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2013 | 145 | 0.030 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2013 | 184 | 0.030 |
Why?
| | Abortion, Induced | 1 | 2014 | 103 | 0.020 |
Why?
| | Random Allocation | 1 | 2013 | 357 | 0.020 |
Why?
| | Organ Size | 1 | 2013 | 479 | 0.020 |
Why?
| | Venous Thrombosis | 1 | 2014 | 185 | 0.020 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2014 | 227 | 0.020 |
Why?
| | Immune Tolerance | 1 | 2014 | 362 | 0.020 |
Why?
| | Cholestasis | 1 | 2014 | 231 | 0.020 |
Why?
| | Sheep | 1 | 2013 | 854 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2018 | 1976 | 0.020 |
Why?
| | Hospitals, Pediatric | 1 | 2013 | 533 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 1484 | 0.020 |
Why?
|
|
Derderian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|